{
    "medicine_id": "92ee0e9f8d38febd7ebcaada38a785f9c32e6789",
    "platform_id": "DB00320",
    "metadata": {
        "name": "D H E 45 1 mg 1mL Injection solution",
        "composition": "1 mg 1mL Dihydroergotamine",
        "clinical_particulars": {
            "therapeutic_indications": "For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes",
            "contraindications": {
                "disease": "Side effects include abdominal pain abnormal speech coma confusion convulsions hallucinations increase and or decrease in blood pressure nausea numbness tingling pain and a bluish color of your fingersand toes slowed breathing vomiting",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes Dihydroergotamine binds with high affinity to 5 HT sub 1D sub a and 5 HT sub 1D sub b receptors It also binds with high affinity to serotonin 5 HT sub 1A sub 5 HT sub 2A sub and 5 HT sub 2C sub receptors noradrenaline a2A a2B and a receptors and dopamine D2L and D3 receptors The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5 HT sub 1D sub receptors",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Dihydroergotamine may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Dihydroergotamine may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Ropinirole may increase the sedative activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Dihydroergotamine may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Methylphenidate"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tolmetin"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Doxapram"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fenoprofen"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Sulindac"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Carprofen"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Phenmetrazine"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Salicylic acid"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Meclofenamic acid"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxaprozin"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Balsalazide"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Olsalazine"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lumiracoxib"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Epicaptopril"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Taxifolin"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxyphenbutazone"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with 1 benzylimidazole"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Benoxaprofen"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Cimicoxib"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Saralasin"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Azapropazone"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Salicylamide"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Kebuzone"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Isoxicam"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Indoprofen"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ibuproxam"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fenbufen"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Etofenamate"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Epirizole"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Moxisylyte"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Flunixin"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Dutasteride"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Valdecoxib"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Finasteride"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Zomepirac"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Acetylsalicylic acid"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Dihydroergotamine may increase the hypertensive activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be decreased when Cabergoline is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Lisuride"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB09097",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Quinagolide"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Dihydroergocornine"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12478",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Piribedil"
                    },
                    {
                        "drugbank-id": "DB12890",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Dihydrexidine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Dihydroergocryptine"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The risk or severity of adverse effects can be increased when Boceprevir is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "Dapoxetine may increase the orthostatic hypotensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Crizotinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "Dihydroergotamine may increase the hypotensive activities of Lurasidone"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Dihydroergotamine may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Sibutramine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Midodrine"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Isoetharine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Etomidate"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Bambuterol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of 4 Bromo 2 5 dimethoxyphenethylamine"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Amibegron"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Solabegron"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Protokylol"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Xylazine"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Detomidine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Reproterol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Octopamine"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Xamoterol"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Racephedrine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "Indacaterol may increase the hypertensive and vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Mirabegron may increase the hypertensive and vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Ergometrine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Salmeterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Salbutamol"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Chloride ion"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Betaxolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Sotalol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Acebutolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Practolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Oxprenolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Dexpropranolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "Bufuralol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bopindolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Indenolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Arotinolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "Levobetaxolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Talinolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Esatenolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Cloranolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Mepindolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Epanolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Tertatolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Propafenone"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Dihydroergotamine may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Cocaine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Milrinone is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Pentoxifylline is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Dipyridamole is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Ibudilast is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Mirodenafil is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Udenafil is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Dihydroergotamine is combined with Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Sildenafil is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The risk or severity of hypotension dyspepsia and headache can be increased when Avanafil is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Fasudil"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Seletracetam"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Tranilast"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Agmatine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Darodipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Caroverine"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Fish oil"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lorpiprazole"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tolcapone"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Meprobamate"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dexbrompheniramine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Metocurine iodide"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methocarbamol"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Triprolidine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Metharbital"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cisatracurium"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mazindol"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dyclonine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Metaxalone"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Trimethobenzamide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atracurium besylate"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Meclizine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Riluzole"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clidinium"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phensuximide"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Progabide"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlordiazepoxide"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Trimethadione"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Palonosetron"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Adinazolam"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Cetirizine"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Naluzotan"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Cinitapride"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Piclozotan"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Almotriptan"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Vilazodone"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Terguride"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Eletriptan may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Furazolidone"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Selegiline can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Safinamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB01321",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Josamycin"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Prazosin"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Labetalol"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Indoramin"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB12230",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Bunazosin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Bucindolol"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Olanzapine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Doxazosin may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Risperidone may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Paliperidone may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "Zuclopenthixol may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Promazine"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Asenapine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Imipramine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Trimipramine"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Silodosin"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Nefazodone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Clozapine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Dihydroergotamine may increase the orthostatic hypotensive hypotensive and antihypertensive activities of Verapamil"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Dihydroergotamine can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The risk or severity of hypotension can be increased when Patent Blue is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of St John s Wort can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Primidone can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Phenobarbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The metabolism of Bosentan can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Efavirenz can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB14240",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Echinacea"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Felbamate can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The metabolism of Eslicarbazepine acetate can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Lesinurad"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Clobazam can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Secobarbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The metabolism of Methohexital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The metabolism of Thiopental can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The metabolism of Ethotoin can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Oxcarbazepine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The metabolism of Methylphenobarbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The metabolism of Thiamylal can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Ketamine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The metabolism of Amobarbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The metabolism of Aprobarbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The metabolism of Barbital can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The metabolism of Barbexaclone can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The metabolism of Eslicarbazepine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Rofecoxib can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Phenylbutazone can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The metabolism of Metamizole can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Nifedipine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Vitamin E"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Flucloxacillin"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00485",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Dicloxacillin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Ivermectin"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB00769",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Hydrocortamate"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Metyrapone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Orlistat"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Formestane"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Testosterone cypionate"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Testosterone enanthate"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be increased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Atazanavir can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Ribociclib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Stiripentol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Naloxone"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Elvitegravir"
                    },
                    {
                        "drugbank-id": "DB11779",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Danoprevir"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The metabolism of Linagliptin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The metabolism of Isradipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Diltiazem can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Nilvadipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Fluvoxamine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The metabolism of Zimelidine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The metabolism of Milnacipran can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Desvenlafaxine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Seproxetine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The metabolism of Indalpine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The metabolism of Barnidipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The metabolism of Benidipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Isoniazid can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Danazol"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB14019",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Fosnetupitant"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Manidipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The metabolism of Citalopram can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Propofol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Lomitapide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01369",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Quinupristin"
                    },
                    {
                        "drugbank-id": "DB01764",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Dalfopristin"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Bifonazole"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB04894",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Vapreotide"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09099",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Somatostatin"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Piperaquine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Theophylline"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Osimertinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The metabolism of Losartan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Irbesartan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The metabolism of Hydralazine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Mibefradil can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Sitaxentan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The metabolism of Efonidipine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Paroxetine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Oxybutynin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Fluticasone propionate can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Dextropropoxyphene can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Tranylcypromine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Phenelzine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The metabolism of Acetazolamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Diazepam can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The metabolism of Ketazolam can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The metabolism of Remacemide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The metabolism of Tofisopam can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The metabolism of Doramectin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The metabolism of Methylergometrine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The metabolism of Epinephrine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Etoricoxib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB00954",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Dirithromycin"
                    },
                    {
                        "drugbank-id": "DB01152",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Candicidin"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB04070",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with 6 Deoxyerythronolide B"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06587",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mitemcinal"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB09308",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Solithromycin"
                    },
                    {
                        "drugbank-id": "DB09309",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Kitasamycin"
                    },
                    {
                        "drugbank-id": "DB11383",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Carbomycin"
                    },
                    {
                        "drugbank-id": "DB11405",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Eprinomectin"
                    },
                    {
                        "drugbank-id": "DB11442",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Oleandomycin"
                    },
                    {
                        "drugbank-id": "DB11459",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Selamectin"
                    },
                    {
                        "drugbank-id": "DB11470",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tildipirosin"
                    },
                    {
                        "drugbank-id": "DB11471",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tilmicosin"
                    },
                    {
                        "drugbank-id": "DB11475",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tylosin"
                    },
                    {
                        "drugbank-id": "DB11554",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tylvalosin"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB13287",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Miocamycin"
                    },
                    {
                        "drugbank-id": "DB13338",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Flurithromycin"
                    },
                    {
                        "drugbank-id": "DB13409",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rokitamycin"
                    },
                    {
                        "drugbank-id": "DB13456",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Midecamycin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Zafirlukast can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Vincristine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vinblastine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Doxorubicin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The metabolism of Vemurafenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Venetoclax can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Acalabrutinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Sorafenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Teniposide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Etoposide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Midostaurin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Bosutinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dabrafenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13633",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mepartricin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Irinotecan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Tolvaptan can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Regorafenib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mefloquine"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01085",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Pilocarpine"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Resveratrol"
                    },
                    {
                        "drugbank-id": "DB05482",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with 7 ethyl 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB05814",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with GPI 1485"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06469",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lestaurtinib"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12532",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Oxetacaine"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Fenofibrate can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Roflumilast can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Vorapaxar can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Ebastine can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of serotonin syndrome can be increased when Sertraline is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "Dihydroergotamine may decrease the hypertensive activities of Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "Dihydroergotamine may decrease the hypertensive activities of Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Dihydroergotamine can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "Thyrotropin alfa may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "Tiratricol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "Thyroid porcine may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "Liotrix may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Levothyroxine may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01038",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Carphenazine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01425",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Alizapride"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB09018",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Bromopride"
                    },
                    {
                        "drugbank-id": "DB09207",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with AS 8112"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Melperone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Azaperone"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12579",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with JNJ 37822681"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Perazine"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Benperidol"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13511",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Clebopride"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB15167",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Fallypride"
                    },
                    {
                        "drugbank-id": "DB15492",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Eticlopride"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Domperidone"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Prucalopride can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "Roxithromycin may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "Telithromycin may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "Cethromycin may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Lefamulin can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Dihydroergotamine is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Dihydroergotamine can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Darunavir"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Dihydroergotamine is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Octreotide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Dihydroergotamine is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Dihydroergotamine can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Berotralstat"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}